Effects of double mutation at two distant IgE-binding sites in the three-dimensional structure of the major house dust mite allergen Der f 2 on IgE-binding and histamine-releasing activity

被引:6
作者
Takai, T
Hatanaka, H
Ichikawa, S
Yokota, T
Inagaki, F
Okumura, Y
机构
[1] Asahi Brewery Co Ltd, Biosci Res & Dev Lab, Moriya, Ibaraki 3020106, Japan
[2] Tokyo Metropolitan Inst Med Sci, Dept Mol Physiol, Bunkyo Ku, Tokyo 1138613, Japan
[3] Japan Womens Univ, Fac Sci, Dept Biol & Mat Sci, Bunkyo Ku, Tokyo 1128681, Japan
[4] Hokkaido Univ, Grad Sch Pharmaceut Sci, Div Struct Biol, Kita Ku, Sapporo, Hokkaido 0600812, Japan
关键词
mite group 2 allergens; IgE epitopes; tertiary structure; allergen engineering; recombinant allergen;
D O I
10.1271/bbb.65.1601
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recently, we reported that introduction of mutations that induced conformational changes of the major mite allergen Der f 2 was an efficient strategy to reduce the allergenicity for safer allergen-specific immunotherapy. In this study, we evaluated another strategy, disruption of two independent IgE epitopes without inducing conformational change. We analyzed allergenicities of the wild-type Der f 2, two single mutants with a mutation at either of the two IgE-binding sites (K15A and K77A), and a double mutant with mutations at both of the sites (K15/77A). Purified recombinant forms of Der f 2 expressed in Escherichia coli had correct disulfide bonds, equivalent apparent molecular masses of approximately 15 kDa, and similar secondary structures. The mutants of Der f 2 had less IgE reactivities than the wild-type Der f 2 and reduced inhibitory activities for IgE-binding to the wild-type Der f 2. However, the mutations did not significantly reduce histamine-releasing activity.
引用
收藏
页码:1601 / 1609
页数:9
相关论文
共 41 条
[1]   SPECIFIC MEASUREMENT OF A MAJOR MITE ALLERGEN, DER F-II, BY AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY SYSTEM USING MONOCLONAL ANTI-DER F-II ANTIBODIES [J].
AKAGAWA, M ;
MORI, T ;
ANDO, T ;
OKUDAIRA, H .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1992, 56 (11) :1725-1727
[2]  
CHAPMAN MD, 1980, J IMMUNOL, V125, P587
[3]   IGE BINDING-STUDIES WITH LARGE PEPTIDES EXPRESSED FROM DER P-II CDNA CONSTRUCTS [J].
CHUA, KY ;
GREENE, WK ;
KEHAL, P ;
THOMAS, WR .
CLINICAL AND EXPERIMENTAL ALLERGY, 1991, 21 (02) :161-166
[4]   ISOLATION OF CDNA CODING FOR THE MAJOR MITE ALLERGEN DER P-II BY IGE PLAQUE IMMUNOASSAY [J].
CHUA, KY ;
DOYLE, CR ;
SIMPSON, RJ ;
TURNER, KJ ;
STEWART, GA ;
THOMAS, WR .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1990, 91 (02) :118-123
[5]   Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy [J].
Ferreira, F ;
Ebner, C ;
Kramer, B ;
Casari, G ;
Briza, P ;
Kungl, AJ ;
Grimm, R ;
Jahn-Schmid, B ;
Breiteneder, H ;
Kraft, D ;
Breitenbach, M ;
Rheinberger, H ;
Scheiner, O .
FASEB JOURNAL, 1998, 12 (02) :231-242
[6]   ALLERGENS OF THE HOUSE DUST MITE DERMATOPHAGOIDES-FARINAE - IMMUNOCHEMICAL STUDIES OF 4 ALLERGENIC FRACTIONS [J].
HAIDA, M ;
OKUDAIRA, H ;
OGITA, T ;
ITO, K ;
MIYAMOTO, T ;
NAKAJIMA, T ;
HONGO, O .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1985, 75 (06) :686-692
[7]   Solution structure of Der f 2, the major mite allergen for atopic diseases [J].
Ichikawa, S ;
Hatanaka, H ;
Yuuki, T ;
Iwamoto, N ;
Kojima, S ;
Nishiyama, C ;
Ogura, K ;
Okumura, Y ;
Inagaki, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :356-360
[8]  
ISHIZAKA T, 1984, PROG ALLERGY, V34, P188
[9]   Recombinant allergens: the future of the diagnosis and treatment of atopic allergy [J].
Kraft, D ;
Ferreira, F ;
Ebner, C ;
Valenta, R ;
Breiteneder, H ;
Susani, M ;
Breitenbach, M ;
Scheiner, O .
ALLERGY, 1998, 53 :62-66
[10]   MOLSCRIPT - A PROGRAM TO PRODUCE BOTH DETAILED AND SCHEMATIC PLOTS OF PROTEIN STRUCTURES [J].
KRAULIS, PJ .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1991, 24 :946-950